Influence of Reninangiotensin System Blockers on the Course of Hypertensive Disease with Type 2 Diabetes and Levels of Apelin and Angiotensin 1-7
Koval S., Yushko K., Starchenko T., Miloslavsky D., Penkova M.
JMBS 2018, 3(2): 71–77 https://doi.org/10.26693/jmbs03.02.071